Author:
Kelly Ronan P.,Close Sandra L.,Farid Nagy A.,Winters Kenneth J.,Shen Lei,Natanegara Fanni,Jakubowski Joseph A.,Ho Mary,Walker Joseph R.,Small David S.
Subject
Pharmacology (medical),Pharmacology
Reference43 articles.
1. Metabolism and disposition of the thienopyridine antiplatelet drugs ticlopidine, clopidogrel, and prasugrel in humans;Farid;J Clin Pharmacol,2010
2. Interactions of two major metabolites of prasugrel, a thienopyridine antiplatelet agent, with the cytochromes P450;Rehmel;Drug Metab Dispos,2006
3. Identification of the human cytochrome P450 enzymes involved in the two oxidative steps in the bioactivation of clopidogrel to its pharmacologically active metabolite;Kazui;Drug Metab Dispos,2010
4. Genetic variants in ABCB1, CYP2C19, and cardiovascular outcomes following treatment with clopidogrel and prasugrel;Mega;Lancet,2010
5. The disposition of prasugrel, a novel thienopyridine, in humans;Farid;Drug Metab Dispos,2007
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献